Decreased expression of long non-coding LOC285194 predicts tumour progression and poor prognosis of hepatocellular carcinoma after curative hepatectomy.

Published in: Postgraduate medical journal (2019)

The low expression level of LOC285194 might be a novel candidate biomarker for predicting tumour progression and poor prognosis in HCC patients who have undergone hepatectomy and might be a potential target for gene therapy.

Keyphrases

poor prognosis
long non coding rna
gene therapy
end stage renal disease
prognostic factors
ejection fraction
newly diagnosed
chronic kidney disease
rectal cancer
patient reported
climate change